Baxter - 38 Year Stock Price History | BAX

Historical daily share price chart and data for Baxter since 1981 adjusted for splits. The latest closing stock price for Baxter as of April 25, 2019 is 76.25.
  • The all-time high Baxter stock price is 81.77, which is 7.2% above the current share price.
  • The Baxter 52-week high stock price is 81.77, which is 7.2% above the current share price.
  • The Baxter 52-week low stock price is 61.39, which is 19.5% below the current share price.
  • The average Baxter stock price for the last 52 weeks is 71.88.
Baxter Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 74.1129 65.3000 81.7700 64.4800 76.2500 15.85%
2018 69.4960 66.4734 77.5850 61.3898 65.8200 2.89%
2017 57.1307 43.5299 65.2059 43.5299 63.9697 47.29%
2016 42.7447 35.9892 48.0126 33.6558 43.4320 17.58%
2015 35.8127 37.5612 40.5418 31.1490 36.9381 -1.63%
2014 36.4733 34.4605 38.9020 33.1456 37.5510 8.40%
2013 34.0089 32.7690 36.5433 31.5890 34.6398 7.28%
2012 27.6880 23.8261 33.0998 23.4037 32.2894 38.42%
2011 25.2865 23.2815 29.0669 22.2821 23.3264 0.05%
2010 22.6492 26.1857 27.7221 18.3599 23.3138 -11.56%
2009 23.9992 24.2421 26.7293 20.6432 26.3609 11.76%
2008 26.8008 25.0439 31.0609 21.2403 23.5863 -6.24%
2007 23.5704 19.8888 26.4740 19.8161 25.1566 26.79%
2006 17.3015 16.1971 20.0000 14.9684 19.8418 24.81%
2005 15.5204 14.4027 17.0361 13.8826 15.8974 10.63%
2004 12.8813 12.3280 14.3902 11.7518 14.3694 15.22%
2003 10.6657 11.4972 12.7080 7.4377 12.4710 11.14%
2002 16.9595 20.8575 23.4107 9.5135 11.2207 -46.73%
2001 18.8187 17.4037 21.5532 15.8251 21.0657 22.85%
2000 13.7315 11.7574 17.2096 9.9243 17.1474 42.52%
1999 12.4071 11.8922 14.3487 11.1375 12.0314 -0.50%
1998 10.6685 9.2480 12.3640 8.9824 12.0917 29.95%
1997 9.1662 7.3317 10.8583 7.3317 9.3052 25.77%
1996 7.3765 6.7898 8.3344 6.5255 7.3984 8.29%
1995 5.7141 4.4492 6.9334 4.2910 6.8322 51.57%
1994 3.9589 3.7047 4.5077 3.3802 4.5077 21.68%
1993 4.0087 4.6695 4.6695 3.0446 3.7047 -21.89%
1992 5.2015 5.6117 5.7376 4.4754 4.7427 -17.07%
1991 4.7862 3.8478 5.7733 3.6018 5.7190 45.97%
1990 3.4144 3.4931 4.0527 2.8441 3.9180 14.41%
1989 2.9065 2.3526 3.4899 2.3526 3.4246 45.57%
1988 2.7255 3.0476 3.3902 2.1877 2.3526 -20.70%
1987 3.1453 2.4659 3.7793 2.3841 2.9668 18.75%
1986 2.3554 2.0116 2.7410 1.9792 2.4983 22.22%
1985 1.8960 1.7041 2.1570 1.6223 2.0441 19.95%
1984 2.1153 3.0175 3.1797 1.5574 1.7041 -43.53%
1983 3.4721 3.0090 4.0642 2.7735 3.0175 -3.89%
1982 2.5174 2.2225 3.2770 2.0279 3.1395 44.42%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $38.988B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.809B 26.28
Medtronic (MDT) Ireland $114.856B 16.79
Stryker (SYK) United States $69.039B 24.64
Boston Scientific (BSX) United States $49.279B 23.63
Zimmer Biomet Holdings (ZBH) United States $25.460B 16.29
Smith & Nephew SNATS (SNN) United Kingdom $16.746B 0.00
Canopy Growth (CGC) Canada $16.646B 0.00
ResMed (RMD) United States $14.578B 27.64
Aurora Cannabis (ACB) Canada $9.230B 65.07
Bio-Rad Laboratories (BIO) United States $8.754B 50.22
Perrigo (PRGO) Ireland $6.685B 10.84
Hill-Rom Holdings (HRC) United States $6.417B 19.85
Insulet (PODD) United States $4.971B 1666.40
GW Pharmaceuticals (GWPH) United Kingdom $4.857B 0.00
ICU Medical (ICUI) United States $4.694B 29.07
Haemonetics (HAE) United States $4.319B 38.31
Hutchison China MediTech (HCM) China $3.951B 0.00
Agios Pharmaceuticals (AGIO) United States $3.335B 0.00
NuVasive (NUVA) United States $3.048B 26.48
Neogen (NEOG) United States $3.014B 49.01
Quidel (QDEL) United States $2.477B 22.16
National Vision Holdings (EYE) United States $2.284B 44.94
Aphria (APHA) $1.955B 0.00
HEXO (HEXO) $1.502B 0.00
Phibro Animal Health (PAHC) United States $1.342B 19.28
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.222B 877.50
AtriCure (ATRC) United States $1.081B 0.00
Lantheus Holdings (LNTH) United States $0.962B 26.00
Omeros (OMER) United States $0.930B 0.00
PetIQ (PETQ) United States $0.874B 25.02
Cerus (CERS) United States $0.826B 0.00
MacroGenics (MGNX) United States $0.805B 0.00
NanoString Technologies (NSTG) United States $0.759B 0.00
Evolus (EOLS) United States $0.721B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.720B 24.51
TG Therapeutics (TGTX) United States $0.706B 0.00
OraSure Technologies (OSUR) United States $0.596B 25.95
Surmodics (SRDX) United States $0.585B 85.02
LeMaitre Vascular (LMAT) United States $0.554B 26.32
Meridian Bioscience (VIVO) United States $0.551B 16.42
Quanterix (QTRX) United States $0.500B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.344B 0.00
Insys Therapeutics (INSY) United States $0.321B 0.00
Utah Medical Products (UTMD) United States $0.319B 20.75
BioLife Solutions (BLFS) United States $0.308B 127.08
Vapotherm (VAPO) United States $0.283B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.223B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.175B 18.69
Bovie Medical (APYX) United States $0.149B 0.00
Chimerix (CMRX) United States $0.129B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.123B 0.00
Surface Oncology (SURF) United States $0.112B 0.00
United-Guardian (UG) United States $0.088B 20.27
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.083B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 12.64